Additional studies are required to evaluate the mechanisms of hepatocarcinogenesis associated with PNPLA3 148M, and whether this genetic is associated with a specific biological subtype of HCC, and can predict the response to treatment. This evidence concerns the gene PNPLA3 and hepatocellular carcinoma.